Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03572413Phase 4Completed
Phase 4, randomised, double-blind trial of rocuronium in surgical trauma, sponsored by Radboud University Medical Center. Primary endpoint: Mononuclear cell responsiveness ex-vivo (TNFα release upon LPS stimulation). Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03572413.